
Applied Therapeutics Inc
NASDAQ:APLT

Intrinsic Value
The intrinsic value of one
APLT
stock under the Base Case scenario is
6.77
USD.
Compared to the current market price of 0.35 USD,
Applied Therapeutics Inc
is
Undervalued by 95%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Fundamental Analysis


Revenue & Expenses Breakdown
Applied Therapeutics Inc
Balance Sheet Decomposition
Applied Therapeutics Inc
Current Assets | 54m |
Cash & Short-Term Investments | 50.8m |
Other Current Assets | 3.2m |
Non-Current Assets | 2.9m |
PP&E | 2.7m |
Other Non-Current Assets | 253k |
Free Cash Flow Analysis
Applied Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Applied Therapeutics Inc
Revenue
|
266k
USD
|
Operating Expenses
|
-109m
USD
|
Operating Income
|
-108.7m
USD
|
Other Expenses
|
65.2m
USD
|
Net Income
|
-43.5m
USD
|
APLT Profitability Score
Profitability Due Diligence
Applied Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Score
Applied Therapeutics Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
APLT Solvency Score
Solvency Due Diligence
Applied Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Applied Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APLT Price Targets Summary
Applied Therapeutics Inc
Dividends
Current shareholder yield for APLT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?